期刊
ANTIOXIDANTS
卷 12, 期 6, 页码 -出版社
MDPI
DOI: 10.3390/antiox12061217
关键词
heme oxygenase-1 (HO-1); reactive oxygen species; cancer; chemoresistance; cytoprotective effect; antioxidant; apoptosis; autophagy
Chemoresistance is a major challenge in cancer therapy. Tumor cells have high levels of reactive oxygen species (ROS), making them more susceptible to further ROS increase than normal cells. However, tumor cells can counteract therapy-induced oxidative stress, leading to chemoresistance. Therefore, understanding the cytoprotective mechanisms of tumor cells is necessary to overcome chemoresistance.
Chemoresistance remains the foremost challenge in cancer therapy. Targeting reactive oxygen species (ROS) manipulation is a promising strategy in cancer treatment since tumor cells present high levels of intracellular ROS, which makes them more vulnerable to further ROS elevation than normal cells. Nevertheless, dynamic redox evolution and adaptation of tumor cells are capable of counteracting therapy-induced oxidative stress, which leads to chemoresistance. Hence, exploring the cytoprotective mechanisms of tumor cells is urgently needed to overcome chemoresistance. Heme oxygenase-1 (HO-1), a rate-limiting enzyme of heme degradation, acts as a crucial antioxidant defense and cytoprotective molecule in response to cellular stress. Recently, emerging evidence indicated that ROS detoxification and oxidative stress tolerance owing to the antioxidant function of HO-1 contribute to chemoresistance in various cancers. Enhanced HO-1 expression or enzymatic activity was revealed to promote apoptosis resistance and activate protective autophagy, which also involved in the development of chemoresistance. Moreover, inhibition of HO-1 in multiple cancers was identified to reversing chemoresistance or improving chemosensitivity. Here, we summarize the most recent advances regarding the antioxidant, antiapoptotic, and pro-autophagy properties of HO-1 in mediating chemoresistance, highlighting HO-1 as a novel target for overcoming chemoresistance and improving the prognosis of cancer patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据